Why it matters: An estimated 15.5 million US adults have used or are currently using GLP-1s for weight loss, according to Gallup
With further validation, these medications might broaden the toolkit for managing opioid and alcohol use disorders, ultimately helping more people avoid relapse, overdose, and severe health consequences, he said in an email
The 30-day rule is essentially universal across reconstituted GLP-1 receptor agonist peptides
If ePA adoption is uneven (e.g
[83] Only a small amount is excreted via the faeces
[Diagram suggestion: three-column flowchart showing decision points at weeks 4, 8, 12, and 16 for each pattern, with "continue," "slow titration," or "re-evaluate" endpoints] Timing the switch: washout vs overlap strategies The pharmacokinetic half-life of semaglutide is approximately 7 days